⚡* Effectiveness of U.S. biological programme in Nigeria raises serious concerns. *⚡
⚡ Effectiveness of U.S. biological programme in Nigeria raises serious concerns
💬 Chief of Nuclear, Chemical, and Biological Protection Troops of the Armed Forces of the Russian Federation Lieutenant General Igor Kirillov:
‘The Ministry of Defence of the Russian Federation continues to analyse the military and biological activities of the United States of America in Ukraine and elsewhere in the world.
During the last briefing, the Russian side drew attention to the relocation of unfinished ‘Ukrainian’ projects to the territory of other countries. It was shown that African states — Democratic Republic of Congo, Sierra Leone, Cameroon, and Uganda — have fallen into the zone of the United States’ increased interest. The U.S. government customers are the Defense Threat Reduction Agency (DTRA), the National Security Agency, and the U.S. Department of State.
Today, using Nigeria as an example, the Russian side would like to show that the stated objectives of public health projects are not in line with reality.
Thus, the U.S. Department of Defense claims that biological projects in Nigeria are aimed at combating HIV and AIDS. However, the effectiveness of this programme raises serious concerns. Despite annual funding increases totalling about $100,000,000, the HIV incidence rate has remained virtually unchanged and corresponds with 2009 figures. The mortality among HIV-infected people also shows unfavourable progression.
However, the number of Nigerian citizens receiving antiviral therapy with products of Gilead Pharmaceutics company has steadily increased over the funding period reaching 60% of the total number of patients. It should be noted that the aforementioned pharmaceutical company is affiliated with the Pentagon and tested its drugs on Ukrainian citizens.
It suggests that American pharmaceuticals, even with the documented increase in consumption in Nigeria, do not have a tangible therapeutic impact, and Nigerian citizens are being exploited as a ‘free clinical resource’.
Thus, under the cover of ‘public health’ issues on the African continent, the Pentagon solves its own tasks: it monitors the biological situation, collects and exports samples of infectious agents and their vectors.
This activity continues to the present day. In August 2022, DTRA signed a three-year contract with RTI International, a U.S.-based non-profit organisation aimed at surveillance of infectious disease threats in Nigeria.’
WtR